The Business Research Company’s in-vitro
diagnostics global market report, covers the year-on-year growth of the global
in-vitro diagnostics market historic and forecast growth. It also includes
chapters on the in-vitro diagnostics market trends, geographical analysis, and
competitive landscape.
Order
the report at:
The global in-vitro diagnostics market size is
expected to reach about $65 billion by 2022, significantly growing at a CAGR of
around 4.5% during the forecast period
In-Vitro
Diagnostics Market Trends
The
in-vitro diagnostics devices (or) equipment manufacturing market consists of
sales of in-vitro diagnostic equipment and related services by entities
(organizations, sole traders and partnerships) that produce in-vitro
diagnostics. This industry includes establishments that produce diagnostic
devices used in microbiological diagnosis, hematological diagnosis, molecular
diagnosis, point of care diagnosis and others.
Companies in this market are
very active with multiple strategic collaborations and agreements. Top companies
in the in-vitro diagnostic market are strategically partnering and
collaborating with other companies to broaden their products, technologies and
services. For instance, In February 2015, Roche acquired Signature Diagnostics
to strengthen its cancer diagnostics effort with Signature’s expertise in both
next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo
Fisher Scientific acquired the Life Technologies Corporation to transform into
a major player in the segment of next-generation sequencing space.
The global in-vitro diagnostics market is primarily driven by favorable government policies, rising awareness about such diseases, new health reforms and increasing economic growth.
Download
a sample of the report:
The global in-vitro diagnostics market report covers the
following regions under the geographical analysis section: Asia Pacific,
Western Europe, North America, Middle East, Africa, South America, and Eastern
Europe. Major countries under each of these regions are also covered under the
country analysis chapters.
With increase in economic growth, health
reforms and increased awareness in in-vitro diagnostics and growing aging
population, the global in-vitro diagnostics market is expected to increase in
potential and scope. TBRC’s report also covers the in-vitro diagnostics drivers
and restraints in the market.
The global in-vitro diagnostics market’s segment shares in
each geographic region are mentioned in the report, along with the historic and
forecast growth rates for each segment presented visually with supporting
reasons to justify the growth rates.
The top companies included in the global in-vitro
diagnostics market report are Siemens Healthineers, F. Hoffmann-La Roche Ltd,
Danaher (Beckman Coulter Inc), Abbott Laboratories Inc, Thermo Fisher
Scientific Inc.
About The Business Research Company:
The Business Research Company is
a Business Intelligence Company which excels in company, market and consumer
research. It has offices in the UK, the US and India and a network of trained
researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment